PureTech Health plc
PRTC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4,828 | $3,330 | $2,090 | $9,979 |
| % Growth | 45% | 59.3% | -79.1% | – |
| Cost of Goods Sold | $0 | $4,933 | $152,433 | $110,471 |
| Gross Profit | $1,257 | -$1,603 | -$136,815 | -$100,492 |
| % Margin | 26% | -48.1% | -6,546.2% | -1,007% |
| R&D Expenses | $54,280 | $96,235 | $116,113 | $81,521 |
| G&A Expenses | $27,491 | $25,180 | $35,669 | $30,761 |
| SG&A Expenses | $27,491 | $48,362 | $35,669 | $30,761 |
| Sales & Mktg Exp. | $0 | $23,182 | $0 | $0 |
| Other Operating Expenses | $58,639 | -$90,043 | -$90,790 | $47,980 |
| Operating Expenses | $140,410 | $54,554 | $60,992 | $160,262 |
| Operating Income | -$136,095 | -$146,199 | -$197,807 | -$150,282 |
| % Margin | -2,818.9% | -4,390.4% | -9,464.4% | -1,506% |
| Other Income/Exp. Net | $159,869 | $110,096 | $105,024 | $91,329 |
| Pre-Tax Income | $23,774 | -$36,103 | -$92,783 | -$58,953 |
| Tax Expense | -$4,008 | $30,525 | -$55,719 | $3,756 |
| Net Income | $53,510 | -$65,697 | -$50,355 | -$60,558 |
| % Margin | 1,108.3% | -1,972.9% | -2,409.3% | -606.9% |
| EPS | 2 | -2.4 | -1.8 | -2.1 |
| % Growth | 183.3% | -33.3% | 14.3% | – |
| EPS Diluted | 2 | -2.4 | -1.8 | -2.1 |
| Weighted Avg Shares Out | 26,966 | 27,630 | 27,975 | 28,659 |
| Weighted Avg Shares Out Dil | 26,966 | 27,630 | 28,476 | 28,659 |
| Supplemental Information | – | – | – | – |
| Interest Income | $22,669 | $16,012 | $5,799 | $214 |
| Interest Expense | $10,037 | $13,488 | $3,953 | $4,714 |
| Depreciation & Amortization | $3,571 | $4,933 | $8,893 | $7,238 |
| EBITDA | $37,382 | -$11,627 | -$188,913 | $26,702 |
| % Margin | 774.3% | -349.2% | -9,038.9% | 267.6% |